Entrar/Registro  
HOME SPANISH
 
Acta Pediátrica de México
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Acta Pediátrica de México >Year 2011, Issue 4


Hernández-Venegas MT, Morfin-Maciel BM, López-Pérez G, Huerta-López J
Clinical characteristics of Mexican asthmatic children seen in a third level care pediatric facility
Acta Pediatr Mex 2011; 32 (4)

Language: Español
References: 31
Page: 202-208
PDF: 457.89 Kb.


Full text




ABSTRACT

Introduction. Asthma is the most common chronic disease in children. It is characterised by coughing, wheezing and breathlessness. Symptoms, seasonality and triggering factors differ for each individual.
Objective. To describe the clinical and spirometric characteristics of Mexican asthmatic children, as well as triggering factors, use of rescue therapy, seasonality and allergic sensitization.
Method. Medical history, clinical evaluation, spirometric tests, and skin prick tests were performed in children attending an allergy outpatient clinic for the first time, with symptoms suggestive of asthma in the last year. Asthma severity was classified according to GINA 2002.
Results. A total of 104 patients between 7 and 18 years old (10.1±2.79) were included. Male gender predominated with a 1.3:1 ratio. 58.7% had mild asthma; 29.8% mild to moderate asthma, and 11.5% moderate to severe asthma. Coughing, wheezing and nocturnal asthma were the predominant symptoms. Forced expiratory volume in one second (FEV1) (%) was between 80 and 117% (92.1±7) in the first group; between 80 and 105% (90±7.4) in the second group; and between 72 and 89% (79.2±4.8) in the third group. 58.2% of the patients had received bronchodilators in the last year (average 1.3 times/week). Most children (89.4%) were sensitized to at least one allergen.
Conclusions. Asthma symptoms, triggering factors, as well as FEV1 vary individually according to asthma severity.


Key words: Asthma, children, wheezing, FEV1, bronchodilators, SABA.


REFERENCIAS

  1. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martínez F et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-91. http://isaac.auckland.ac.nz/

  2. Chronic respiratory diseases, World Health Organization. Disponible en: http://www.who.int/respiratory/asthma Consultado el 20 de febrero, 2011.

  3. Larenas-Linnemannn D, Ortega Martell JA, del Río-Navarro B, Rodríguez-Pérez N, Arias-Cruz A, Estrada-Carmona A y cols. Guía Mexicana de Práctica Clínica de Inmunoterapia 2011. Rev Alergia Mex 2011;58:1-85.

  4. Bacharier LB, Bomer A, Carlsen KH, Eigenmann PA, Frischer T, Götz M et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63(1):5-34.

  5. Crapo RO, Jensen RL, Lockey JE, Aldrich V, Elliott CG. Normal spirometric values in healthy Hispanic Americans. Chest 1990;98:1435-9.

  6. Bateman ED, Boulet LP, Cruz A, Fitzgerald M, Haatela T, Levy M y cols. Guía de bolsillo para el manejo y prevención del asma 2010. Global Initiative for Asthma, 2010. Disponible en: www.ginasthma.com

  7. López-Pérez G, Morfin-Maciel B, Vergara VJ. Las enfermedades alérgicas como un problema de salud pública. Alergia, Asma Inmunol Ped 1997;6(2):36-7.

  8. Weiss ST, Speizer FE. Epidemiology and natural history. En Weiss EB, Stein M, editores: Bronchial Asthma: mechanisms and therapeutics. 3ª. Ed. Boston: Little Brown; 1993.p.15-25.

  9. Sears MR, Burrows B, Flannery EM, Herbison GP, Holdaway MD. Atopy in Childhood. I. Gender and allergen related risks for development of hay fever and Asthma. Clin Exp Allergy 1993;23(11):941-8.

  10. Horwood LJ, Fergusson DM, Shannon FT. Social and familial factors in the development of early childhood asthma. Pediatrics 1985; 75:859-68.

  11. López Campos C, Carrillo Lucero JM, López Campos JE, Rincón Castañeda C, Velasco Gutiérrez JM, Cairo Cueto SM y cols. Prevalence and severity of asthma in 6 and 7 yearold children from Torreon, Coahuila, Mexico. Rev Alerg Mex 2008;55(4):148-52.

  12. González GJG, Barrera GLE, Arévalo OMA. Prevalencia del asma bronquial en la ciudad de Guadalajara, Jalisco, México. Alergia 1992;39:3-7.

  13. Martínez FD, Wright AL, Taussing LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Eng J Med 1995;332(3):133-8.

  14. Scheuerman O, Meyerovitch J, Marcus N, Hoffer V, Batt E, Garty BZ. The September epidemic of asthma in Israel. J Asthma 2009;46(7):652-5.

  15. Mireku N, Wang Y, Ager J, Reddy RC, Baptist AP. Changes in weather and the effects on pediatric asthma exacerbations. Ann Allergy Asthma Immunol 2009;103(3):220-4.

  16. Wu P, Duppont WD, Griffin MR, Carroll KN, Mitchel EF, Gebretsadik T et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med 2008;178(11):1123-9.

  17. Meneses GF, Romieu I, Sienra Monge JJ, Huerta López J, Ruiz Velasco S. Asthma in a population of children and its relation to airborne environmental pollutants in Mexico City. A cohort study. Mexico 1991. Experimental design. Rev Alerg Mex 1996;43(3):66-72.

  18. Terán LM, Haselbarth-López MM, Quiroz-García DL. Allergy, Pollen and the environmental. Gac Med Mex 2009;145(3):215-22.

  19. Platts-Mills TAE. Is there a dose-response relationship between exposure to indoor allergens and symptoms of asthma? J Allergy Clin Immunol 1995;96:435-40.

  20. Godfrey S, Konig P. Excercise induced bronchial lability in wheezing children and their families. Pediatrics 1975;56:851-4.

  21. Singh AM, Busse WW. Asthma exacerbations: Aetiology. Thorax 2006;61:809-16.

  22. Young S, Le Souef PN, Geelhoed GC, Stick SM, Turner KJ, Landau LI. The influence of a family history of asthma and parenteral smoking on airway responsiveness in early infancy. N Eng J Med 1991;324:1168-93.

  23. Hastert TA, Babey SH, Brown ER, Meng YY. Pets and smoking in the home associated with asthma symptoms and asthma-like breathing problems. Policy Brief UCLA Cent Health Policy Res 2007;2:1-7.

  24. López Pérez G, Morfin Maciel B, Huerta López J, Mejía Covarrubias F, López López J, Aguilar G y cols. Prevalencia de las enfermedades alérgicas en la Ciudad de México. Rev Alerg Mex 2009;56(3):72-9.

  25. Orejas García C, Pascual Pascual T, Alzueta Alvarez A, Bazús González T, Martínez González del Río J, Escudero Bueno C. Cough variant asthma. Clinical and functional characteristics. Report of 63 cases. Arch Bronchoneumol 1998;34(5):232-6.

  26. Simon HK. Caregiver knowledge and delivery of commonly prescribed medication (albuterol) for children. Arch Pediatr Adolesc Med 1999;153:615-19.

  27. Blaiss MS, Meltzer E, Murphy KR, Nathan R, Stoloff SW. Asthma insight and management (AIM): A National Survey of Asthma Patients, Public and Healthcare practitioners. Disponible en: www.takingaimatasthma.com

  28. Bjerg A, Sandström T, Lundbäck B y Rönmark E. Time trends in asthma and wheeze in Swedish children 1996-2006: prevalence and risk factors by sex. Allergy 2010;65(1):48-55.

  29. Navarro A, Valero A, Juliá B, Quirce S. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. J Invest Allergol Clin Immunol 2008;18(4):233-8.

  30. Aït –Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J et al. Global map of the prevalence of symptoms of rhinoconjuntivitis in children. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009;64(1):123-48.

  31. Fernández-Vega M, Vargas MH, Pineda-Regalado J, Chapela Mendoza R, Salas Hernández J. Características de pacientes asmáticos mexicanos atendidos en consulta externa. Rev Invest Clin 2005;57(4):513-21.






>Journals >Acta Pediátrica de México >Year 2011, Issue 4
 

· Journal Index 
· Links 






       
Copyright 2019